$172M in IPOs from Wave Life Sciences, Voyager Therapeutics
The biotech IPO parade marches on with two IPOs: Wave Life Sciences priced out at $102 million today, and Voyager Life Sciences raised $70 million.
RNA therapeutics has a new player: Japan/U.S. collab WaVe Therapeutics raises $18M Series A
There’s a new player in the RNA therapeutics space: WaVe Life Sciences, a Boston-Japan biotech collaboration that just closed out an $18 million Series A. It’s working on a pipeline of stereopure nucleic acid therapeutics, which includes antisense and exon-skipping drug candidates. It says it’s working to build the “first and only” platform that can produce […]
presented by
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!